Drugmakers’ deal making will plow ahead despite antitrust scrutiny, analysts say
July 12, 2023 at 15:59 PM EDT
Big pharma goes shopping as "patent cliff" puts more than $225 billion in revenues at risk.
Photography by Christophe Tomatis